{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:21:50Z","timestamp":1780420910634,"version":"3.54.1"},"reference-count":79,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2022.0406","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T03:48:23Z","timestamp":1674618503000},"source":"Crossref","is-referenced-by-count":33,"title":["Urinary incontinence and pelvic organ prolapse in women"],"prefix":"10.3238","author":[{"given":"Ralf","family":"Tunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaven","family":"Bae\u00dfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kn\u00fcpfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"10.3238\/arztebl.m2022.0406_ref1","doi-asserted-by":"crossref","unstructured":"Lopez-Lopez AI, Sanz-Valero J, Gomez-Perez L, Pastor-Valero M: Pelvic floor: vaginal or caesarean delivery? A review of systematic reviews. Int Urogynecol J 2021; 7: 1663-73.","DOI":"10.1007\/s00192-020-04550-8"},{"key":"10.3238\/arztebl.m2022.0406_ref2","doi-asserted-by":"crossref","unstructured":"Gyhagen M, Bullarbo M, Nielsen TF, Milsom I: Prevalence and risk factors for pelvic organ prolapse 20 years after childbirth: a national cohort study in singleton primiparae after vaginal or caesarean delivery. BJOG 2013; 120: 152–60.","DOI":"10.1111\/1471-0528.12020"},{"key":"10.3238\/arztebl.m2022.0406_ref3","doi-asserted-by":"crossref","unstructured":"Wilson D, Dorman J, Milsom I, Freeman R: UR-CHOICE: can we provide mothers-to-be with information about the risk of future pelvic floor dysfunction? Int Urogynecol J 2014; 25: 1449–52.","DOI":"10.1007\/s00192-014-2376-z"},{"key":"10.3238\/arztebl.m2022.0406_ref4","doi-asserted-by":"crossref","unstructured":"H\u00fcbner M, Rothe C, Plappert C, Bae\u00dfler K: Aspects of pelvic floor protection in spontaneous delivery—a review. Geburtshilfe Frauenheilkd 2022; 82: 400–09.","DOI":"10.1055\/a-1515-2622"},{"key":"10.3238\/arztebl.m2022.0406_ref5","doi-asserted-by":"crossref","unstructured":"Woodley StJ, Lawrenson P, Boyle R, et al.: Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev 2020; 5: CD007471.","DOI":"10.1002\/14651858.CD007471.pub4"},{"key":"10.3238\/arztebl.m2022.0406_ref6","doi-asserted-by":"crossref","unstructured":"Akervall S, Al-Mukhtar Othman J, Molin M, Gyhagen M: Symptomatic pelvic organ prolapse in middle-aged women: a national matched cohort study on the influence of childbirth. Am J Obstet Gynecol 2020; 222: 356.e1–e14.","DOI":"10.1016\/j.ajog.2019.10.007"},{"key":"10.3238\/arztebl.m2022.0406_ref7","doi-asserted-by":"crossref","unstructured":"Hage-Franse MAH, Wiezer M, Otto A, et al.: Pregnancy- and obstetric-related risk factors for urinary incontinence, fecal incontinence, or pelvic organ prolapse later in life: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2021; 100: 373–82.","DOI":"10.1111\/aogs.14027"},{"key":"10.3238\/arztebl.m2022.0406_ref8","doi-asserted-by":"crossref","unstructured":"Hay-Smith EJ, Herderschee R, Dumoulin C, Herbison GP: Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev 2011; 12: CD009508.","DOI":"10.1002\/14651858.CD009508"},{"key":"10.3238\/arztebl.m2022.0406_ref9","unstructured":"Reisenauer C, Naumann G: AWMF-Leitlinie Harninkontinenz, Registernummer 015–091, 2022. https:\/\/register.awmf.org\/assets\/guidelines\/015–091l_S2k_Harninkontinenz-der-Frau_2022–03.pdf (last accessed on 3 January 2023)"},{"key":"10.3238\/arztebl.m2022.0406_ref10","doi-asserted-by":"crossref","unstructured":"Mansfield KJ, Chandran JJ, Vaux KJ, et al.: Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa. J Pharmacol Exp Ther 2009; 328: 893–9.","DOI":"10.1124\/jpet.108.145508"},{"key":"10.3238\/arztebl.m2022.0406_ref11","doi-asserted-by":"crossref","unstructured":"Schneider T, Michel MC: Anticholinergic treatment of overactive bladder syndrome. Is it all the same? Urologe A 2009: 48; 245–9.","DOI":"10.1007\/s00120-008-1915-y"},{"key":"10.3238\/arztebl.m2022.0406_ref12","doi-asserted-by":"crossref","unstructured":"Wiedemann A, Becher K, Bojack B, Ege S, von der Heide S, Kirschner-Hermanns R: S2e-Leitlinie 084–001, Harninkontinenz bei geriatrischen Patienten, Diagnostik und Therapie, 2019. https:\/\/register.awmf.org\/assets\/guidelines\/084–001l_S2e_Harninkontinenz_geriatrische _Patienten_Diagnostik-Therapie_2019–01.pdf (last accessed on 3 January 2023)","DOI":"10.1055\/a-0915-5028"},{"key":"10.3238\/arztebl.m2022.0406_ref13","doi-asserted-by":"crossref","unstructured":"Kay G, Crook T, Rekeda L, et al.: Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol 2006; 50: 317–26.","DOI":"10.1016\/j.eururo.2006.03.057"},{"key":"10.3238\/arztebl.m2022.0406_ref14","doi-asserted-by":"crossref","unstructured":"Staskin D, Kay G, Tannenbaum C, et al.: Trospium chloride is undetectable in the older human central nervous system. J Am Geriatr Soc 2010; 58: 1618–9.","DOI":"10.1111\/j.1532-5415.2010.02988.x"},{"key":"10.3238\/arztebl.m2022.0406_ref15","doi-asserted-by":"crossref","unstructured":"Novack GD, Lewis RA, Vogel R, et al.: Randomized, double-masked, placebo controlled study to assess the ocular safety of mirabegron in healthy volunteers. J Ocul Pharmacol Ther 2013; 29: 674–80.","DOI":"10.1089\/jop.2012.0254"},{"key":"10.3238\/arztebl.m2022.0406_ref16","doi-asserted-by":"crossref","unstructured":"Chapple C, Khullar V, Nitti VW, et al.: Efficacy of the beta3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials. Eur Urol 2015; 67: 11–4.","DOI":"10.1016\/j.eururo.2014.06.052"},{"key":"10.3238\/arztebl.m2022.0406_ref17","doi-asserted-by":"crossref","unstructured":"Wagg A, Cardozo L, Nitti VW, et al.: The efficacy and tolerability of the beta3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients. Age Ageing 2014; 43: 666–75.","DOI":"10.1093\/ageing\/afu017"},{"key":"10.3238\/arztebl.m2022.0406_ref18","doi-asserted-by":"crossref","unstructured":"Chapple CR, Nazir J, Hakimi Z: Persistence and adherence with mirabegron versus antimuscarinic agents in patients with overactive bladder: a retrospective observational study in UK clinical practice. Eur Urol 2017; 72: 389–99.","DOI":"10.1016\/j.eururo.2017.01.037"},{"key":"10.3238\/arztebl.m2022.0406_ref19","doi-asserted-by":"crossref","unstructured":"Tunn R, Sch\u00e4r G, Aigm\u00fcller T, H\u00fcbner M: Operative Therapie des Deszensus. In: Tunn R, Hanzal E, Perucchini D (eds.): Urogyn\u00e4kologie in Praxis und Klinik. Berlin, Boston: Walter de Gruyter 2021; 466.","DOI":"10.1515\/9783110657906"},{"key":"10.3238\/arztebl.m2022.0406_ref20","doi-asserted-by":"crossref","unstructured":"van Kerrebroeck P, Abrams P, Lange R, et al.: Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 2004; 111: 249–57.","DOI":"10.1111\/j.1471-0528.2004.00067.x"},{"key":"10.3238\/arztebl.m2022.0406_ref21","doi-asserted-by":"crossref","unstructured":"Ghoniem GM, Van Leeuwen JS, Elser DM, et al.: A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. J Urol 2005; 173: 1647–53.","DOI":"10.1097\/01.ju.0000154167.90600.c6"},{"key":"10.3238\/arztebl.m2022.0406_ref22","unstructured":"Ulmsten U, Johnson P, Petros P: Intravaginal slingplasty. Zentralbl Gynakol 1994; 116: 398–404."},{"key":"10.3238\/arztebl.m2022.0406_ref23","doi-asserted-by":"crossref","unstructured":"Ulmsten U, Petros P: Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence. Scand J Urol Nephrol 1995; 29: 75–82.","DOI":"10.3109\/00365599509180543"},{"key":"10.3238\/arztebl.m2022.0406_ref24","doi-asserted-by":"crossref","unstructured":"Nilsson CG, Palva K, Aarnio R, et al.: Seventeen years‘ follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J 2013; 24: 1265–9.","DOI":"10.1007\/s00192-013-2090-2"},{"key":"10.3238\/arztebl.m2022.0406_ref25","doi-asserted-by":"crossref","unstructured":"Kuszka A, Gamper M, Walser C, Kociszewski J, Viereck V: Erbium: YAG laser treatment of female stress urinary incontinence: midterm data. Int Urogynecol J 2020; 31: 1859–66.","DOI":"10.1007\/s00192-019-04148-9"},{"key":"10.3238\/arztebl.m2022.0406_ref26","doi-asserted-by":"crossref","unstructured":"Chancellor MB, Migliaccio-Walle K, Bramley TJ, Chaudhari SL, Corbell C, Globe D: Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder. Clin Ther 2013; 35: 1744–51.","DOI":"10.1016\/j.clinthera.2013.08.017"},{"key":"10.3238\/arztebl.m2022.0406_ref27","doi-asserted-by":"crossref","unstructured":"Dowson C, Sahai A, Watkins J, Dasgupta P, Khan MS: The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double blind placebo-controlled trial. Int J Clin Pract 2011; 65: 698–704.","DOI":"10.1111\/j.1742-1241.2011.02663.x"},{"key":"10.3238\/arztebl.m2022.0406_ref28","doi-asserted-by":"crossref","unstructured":"Marcelissen TA, Rahnama‘i MS, Snijkers A, Schurch B, De Vries P: Long-term follow up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms. World J Urol 2017; 35: 307–11.","DOI":"10.1007\/s00345-016-1862-y"},{"key":"10.3238\/arztebl.m2022.0406_ref29","doi-asserted-by":"crossref","unstructured":"Siegel S, Noblett K, Mangel J, et al.: Five-year follow up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. J Urol 2018; 199: 229–36.","DOI":"10.1016\/j.juro.2017.07.010"},{"key":"10.3238\/arztebl.m2022.0406_ref30","doi-asserted-by":"crossref","unstructured":"Groenendijk PM, Lycklama \u00e0 Nyeholt AA, Heesakkers JP, van Kerrebroeck PE, et al.: Sacral nerve stimulation study group. Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence. BJU Int 2008; 101: 325–9.","DOI":"10.1111\/j.1464-410X.2007.07258.x"},{"key":"10.3238\/arztebl.m2022.0406_ref31","doi-asserted-by":"crossref","unstructured":"Hampel C, Neisius A, Thomas C, Thüroff JW, Roos F: Vesicovaginal fistula. Incidence, etiology and phenomenology in Germany. Urologe A 2015; 54: 349–58.","DOI":"10.1007\/s00120-014-3679-x"},{"key":"10.3238\/arztebl.m2022.0406_ref32","doi-asserted-by":"crossref","unstructured":"Moergeli C, Tunn R: Vaginal repair of nonradiogenic urogenital fistulas. In Urogynecol J 2021; 32: 2449–54.","DOI":"10.1007\/s00192-020-04496-x"},{"key":"10.3238\/arztebl.m2022.0406_ref33","doi-asserted-by":"crossref","unstructured":"Baessler K, Aigmuller T, Albrich S, et al.: Diagnosis and therapy of female pelvic organ prolapse. Guideline of the DGGG, SGGG and OEGGG (S2e-Level, AWMF Registry Number 015\/006, April 2016). Geburtshilfe Frauenheilkd 2016; 76: 1287–301.","DOI":"10.1055\/s-0042-119648"},{"key":"10.3238\/arztebl.m2022.0406_ref34","doi-asserted-by":"crossref","unstructured":"Maher CF, Baessler KK, Barber MD, et al.: Summary: 2017 international consultation on incontinence evidence-based surgical pathway for pelvic organ prolapse. Female Pelvic Med Reconstr Surg 2020; 26: 30–6.","DOI":"10.1097\/SPV.0000000000000591"},{"key":"10.3238\/arztebl.m2022.0406_ref35","doi-asserted-by":"crossref","unstructured":"Chen L, Lisse S, Larson K, Berger MB, Ashton-Miller JA, DeLancey JOL: Structural failure sites in anterior vaginal wall prolapse: identification of a collinear triad. Obstet Gynecol 2016; 128: 853–62.","DOI":"10.1097\/AOG.0000000000001652"},{"key":"10.3238\/arztebl.m2022.0406_ref36","doi-asserted-by":"crossref","unstructured":"Gutman R, Maher C: Uterine-preserving POP surgery. Int Urogynecol J 2013; 24: 1803–13.","DOI":"10.1007\/s00192-013-2171-2"},{"key":"10.3238\/arztebl.m2022.0406_ref37","doi-asserted-by":"crossref","unstructured":"Mowat A, Maher D, Baessler K, Christmann-Schmid C, Haya N, Maher C: Surgery for women with posterior compartment prolapse. Cochrane Database Syst Rev 2018; 3: CD012975.","DOI":"10.1002\/14651858.CD012975"},{"key":"10.3238\/arztebl.m2022.0406_ref38","doi-asserted-by":"crossref","unstructured":"Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J: Surgery for women with apical vaginal prolapse. Cochrane Database Syst Rev 2016; 10: CD012376.","DOI":"10.1002\/14651858.CD012376"},{"key":"10.3238\/arztebl.m2022.0406_ref39","doi-asserted-by":"crossref","unstructured":"Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Marjoribanks J: Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse. Cochrane Database Syst Rev 2016; 2: CD012079.","DOI":"10.1002\/14651858.CD012079"},{"key":"10.3238\/arztebl.m2022.0406_ref40","doi-asserted-by":"crossref","unstructured":"Baessler K, Christmann-Schmid C, Maher C, Haya N, Crawford TJ, Brown J: Surgery for women with pelvic organ prolapse with or without stress urinary incontinence. Cochrane Database Syst Rev 2018; 8: CD013108.","DOI":"10.1002\/14651858.CD013108"},{"key":"10.3238\/arztebl.m2022.0406_ref41","doi-asserted-by":"crossref","unstructured":"Bascur-Castillo C, Carrasco-Porti\u00f1o M, Valenzuela-Peters R, Orellana-Gaete L, Viveros-Allende V, Ruiz Cantero MT: Effect of conservative treatment of pelvic floor dysfunctions in women: an umbrella review. Int J Gynaecol Obstet 2022; 159: 372–91.","DOI":"10.1002\/ijgo.14172"},{"key":"10.3238\/arztebl.m2022.0406_ref42","unstructured":"Lange R, H\u00fcbner M, Tunn R: Pessartherapie beim Descensus urogenitalis. In: Tunn R, Hanzal E, Perucchini D (eds.): Urogyn\u00e4kologie in Praxis und Klinik. Berlin, Boston: Walter de Gruyter 2021; 442–50."},{"key":"10.3238\/arztebl.m2022.0406_ref43","doi-asserted-by":"crossref","unstructured":"Lisibach A, Gallucci G, Benelli V, et al.: Evaluation of the association of anticholinergic burden and delirium in older hospitalised patients–a cohort study comparing 19 anticholinergic burden scales. Br J Clin Pharmacol 2022; 88: 4915–27.","DOI":"10.1111\/bcp.15432"},{"key":"10.3238\/arztebl.m2022.0406_ref44","doi-asserted-by":"crossref","unstructured":"Eibler KS, Alperin M, Khan A, et al.: Outcomes of vaginal prolapse surgery among female medicare beneficiaries: the role of apical support. Obstet Gynecol 2013; 122: 981–7.","DOI":"10.1097\/AOG.0b013e3182a8a5e4"},{"key":"10.3238\/arztebl.m2022.0406_ref45","doi-asserted-by":"crossref","unstructured":"Ng-Stollmann N, F\u00fcnfgeld C, Gabriel B, et al.: The international discussion and the new regulations concerning transvaginal mesh implants in pelvic organ prolapse surgery. Int Urogynecol J 2020; 31: 1997–2002.","DOI":"10.1007\/s00192-020-04407-0"},{"key":"10.3238\/arztebl.m2022.0406_ref46","doi-asserted-by":"crossref","unstructured":"Antosh DD, Dieter AA, Balk EM, et al.: Sexual function after pelvic organ prolapse surgery: a systematic review comparing different approaches to pelvic floor repair. Am J Obstet Gynecol 2021; 225: 475.e1–e19.","DOI":"10.1016\/j.ajog.2021.05.042"},{"key":"10.3238\/arztebl.m2022.0406_ref47","doi-asserted-by":"crossref","unstructured":"Verghese TS, Middleton L, Cheed V, Leighton L, Daniels J, Latthe PM: LOTUS trial collaborative group. Randomised controlled trial to investigate the effectiveness of local oestrogen treatment in postmenopausal women undergoing pelvic organ prolapse surgery (LOTUS): a pilot study to assess feasibility of a large multicentre trial. BMJ Open 2020; 10: e025141.","DOI":"10.1136\/bmjopen-2018-025141"},{"key":"10.3238\/arztebl.m2022.0406_ref48","doi-asserted-by":"crossref","unstructured":"Chiengthong K, Ruanphoo P, Chatsuwan T, Bunyavejchevin S: Effect of vaginal estrogen in postmenopausal women using vaginal pessary for pelvic organ prolapse treatment: a randomized controlled trial. Int Urogynecol J 2022; 33: 1833–38.","DOI":"10.1007\/s00192-021-04821-y"},{"key":"10.3238\/arztebl.m2022.0406_ref49","doi-asserted-by":"crossref","unstructured":"Lillemon JN, Karstens L, Nardos R, Garg B, Boniface ER, Gregory WT: The impact of local estrogen on the urogenital microbiome in genitourinary syndrome of menopause: A randomized-controlled trial. Female Pelvic Med Reconstr Surg 2022; 28: e157–e62.","DOI":"10.1097\/SPV.0000000000001170"},{"key":"10.3238\/arztebl.m2022.0406_ref50","doi-asserted-by":"crossref","unstructured":"Propst K, Mellen C, O‘Sullivan DM, Tulikangas PK: Timing of office-based pessary care: a randomized controlled trial. Obstet Gynecol 2020; 135: 100–5.","DOI":"10.1097\/AOG.0000000000003580"},{"key":"10.3238\/arztebl.m2022.0406_ref51","doi-asserted-by":"crossref","unstructured":"Boyd SS, Subramanian D, Propst K, O‘Sullivan D, Tulikangas P: Pelvic organ prolapse severity and genital hiatus size with long-term pessary use. Female Pelvic Med Reconstr Surg 2021; 27: e360–e2.","DOI":"10.1097\/SPV.0000000000000937"},{"key":"10.3238\/arztebl.m2022.0406_ref52","doi-asserted-by":"crossref","unstructured":"Nekkanti S, Wu JM, Hundley AF, Hudson C, Pandya LK, Dieter AA: A randomized trial comparing continence pessary to continence device (Poise Impressa\u00ae) for stress incontinence. Int Urogynecol J 2022; 33: 861–8.","DOI":"10.1007\/s00192-021-04967-9"},{"key":"10.3238\/arztebl.m2022.0406_ref53","doi-asserted-by":"crossref","unstructured":"Stafne SN, Dalbye R, Kristiansen OM, et al.: Antenatal pelvic floor muscle training and urinary incontinence: a randomized controlled 7-year follow-up study. Int Urogynecol J 2022; 33: 1557–65.","DOI":"10.1007\/s00192-021-05028-x"},{"key":"10.3238\/arztebl.m2022.0406_ref54","doi-asserted-by":"crossref","unstructured":"Luginbuehl H, Lehmann C, Koenig I, Kuhn A, Buergin R, Radlinger L: Involuntary reflexive pelvic floor muscle training in addition to standard training versus standard training alone for women with stress urinary incontinence: a randomized controlled trial. Int Urogynecol J 2022; 33: 531–40.","DOI":"10.1007\/s00192-021-04701-5"},{"key":"10.3238\/arztebl.m2022.0406_ref55","doi-asserted-by":"crossref","unstructured":"De Marco M, Arbieto ERM, Da Roza TH, Resende APM, Santos GM: Effects of visceral manipulation associated with pelvic floor muscles training in women with urinary incontinence: a randomized controlled trial. Neurourol Urodyn 2022; 41: 399–408.","DOI":"10.1002\/nau.24836"},{"key":"10.3238\/arztebl.m2022.0406_ref56","doi-asserted-by":"crossref","unstructured":"Leonardo K, Seno DH, Mirza H, Afriansyah A: Biofeedback-assisted pelvic floor muscle training and pelvic electrical stimulation in women with overactive bladder: a systematic review and meta-analysis of randomized controlled trials. Neurourol Urodyn 2022; 41: 1258–69.","DOI":"10.1002\/nau.24984"},{"key":"10.3238\/arztebl.m2022.0406_ref57","doi-asserted-by":"crossref","unstructured":"Wang T, Wen Z, Li M: The effect of pelvic floor muscle training for women with pelvic organ prolapse: a meta-analysis. Int Urogynecol J 2022; 33: 1789–1801.","DOI":"10.1007\/s00192-022-05139-z"},{"key":"10.3238\/arztebl.m2022.0406_ref58","doi-asserted-by":"crossref","unstructured":"Chapple CT, Dvorak V, Radziszewaki P, et al.: A phase II dose-ranging study of mirabegron in patients with overactive bladder. Int Urogynecol J 2013; 24: 1447–58.","DOI":"10.1007\/s00192-013-2042-x"},{"key":"10.3238\/arztebl.m2022.0406_ref59","doi-asserted-by":"crossref","unstructured":"Wagg A, Arumi D, Herschorn S, et al.: A pooled analysis of the efficacy of fesoterodine for the treatment of overactive bladder, and the relationship between safety, co-morbidity and polypharmacy in patients aged 65 years or older. Age and Ageing 2017; 46: 620–6.","DOI":"10.1093\/ageing\/afw252"},{"key":"10.3238\/arztebl.m2022.0406_ref60","doi-asserted-by":"crossref","unstructured":"Nitti V, Dmochowski R, Herschorn S, et al.: OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol 2013; 189: 2186–93.","DOI":"10.1016\/j.juro.2012.12.022"},{"key":"10.3238\/arztebl.m2022.0406_ref61","doi-asserted-by":"crossref","unstructured":"Sand P, Dmochowski R, Reddy J, van der Meulen E: Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double blind, placebo controlled, parallel group study. J Urol 2013; 190: 958–64.","DOI":"10.1016\/j.juro.2013.02.037"},{"key":"10.3238\/arztebl.m2022.0406_ref62","unstructured":"Mirzaei M, Daneshpajooh, Anvari S, Dozchizadeh S, Teimourian M: Evaluation of the clinical efficacy and complications of duloxetine in comparison to solifenacin in the treatment of overactive bladder disease in women: a randomized clinical trial. Urol J 2021; 18: 543–8."},{"key":"10.3238\/arztebl.m2022.0406_ref63","doi-asserted-by":"crossref","unstructured":"Schellart RP, Rengerink KO, Van der Aa F, Lucot JP: A randomized comparison of a single-incision midurethral sling and a transobturator midurethral sling in women with stress urinary incontinence: results of 12-mo follow-up. Eur Urol 2014; 66: 1179–85.","DOI":"10.1016\/j.eururo.2014.07.027"},{"key":"10.3238\/arztebl.m2022.0406_ref64","doi-asserted-by":"crossref","unstructured":"Itkonen Freitas AM, Isaksson C, Rahkola-Soisalo P, Tulokas S, Mentula M, Mikkola TS: Tension-free vaginal tape and polyacrylamide hydrogel injection for primary stress urinary incontinence: 3-year follow up from a randomized clinical trial. J Urol 2022; 208: 658–67.","DOI":"10.1097\/JU.0000000000002720"},{"key":"10.3238\/arztebl.m2022.0406_ref65","doi-asserted-by":"crossref","unstructured":"Dogan O, Kaya AE, Pulatoglu C, Basbug A, Yassa M: A randomized comparison of a single-incision needleless (Contasure-needleless\u00ae) mini-sling versus an inside-out transobturator (Contasure-KIM\u00ae) mid-urethral sling in women with stress urinary incontinence: 24-month follow-up results. Int Urogynecol J 2018; 29: 1387–95.","DOI":"10.1007\/s00192-018-3624-4"},{"key":"10.3238\/arztebl.m2022.0406_ref66","doi-asserted-by":"crossref","unstructured":"Hold\u00f8 B, Verelst M, Svenningsen R, Milsom I, Skjeldestad FE: Long-term clinical outcomes with the retropubic tension-free vaginal tape (TVT) procedure compared to Burch colposuspension for correcting stress urinary incontinence (SUI). Int Urogynecol J 2017; 28: 1739–46.","DOI":"10.1007\/s00192-017-3345-0"},{"key":"10.3238\/arztebl.m2022.0406_ref67","doi-asserted-by":"crossref","unstructured":"Lau HH, Su TH, Huang WC, Hsieh CH, Su CH, Chang RC: A prospective study of transobturator tape as treatment for stress urinary incontinence after transvaginal mesh repair. Int Urogynecol J 2013; 24: 1639–44.","DOI":"10.1007\/s00192-012-2033-3"},{"key":"10.3238\/arztebl.m2022.0406_ref68","doi-asserted-by":"crossref","unstructured":"Ward KL, Hilton P: Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. BJOG 2008; 115: 226–33.","DOI":"10.1111\/j.1471-0528.2007.01548.x"},{"key":"10.3238\/arztebl.m2022.0406_ref69","doi-asserted-by":"crossref","unstructured":"Karmakar D, Mostafa A, Abdel-Fattah M: Long-term outcomes of transobturator tapes in women with stress urinary incontinence: E-TOT randomised controlled trial. BJOG 2017; 124: 973–81.","DOI":"10.1111\/1471-0528.14561"},{"key":"10.3238\/arztebl.m2022.0406_ref70","doi-asserted-by":"crossref","unstructured":"Dejene SZ, Funk MJ, Pate V, Wu JM: Long-term outcomes after midurethral mesh sling surgery for stress urinary incontinence. Female Pelvic Med Reconstr Surg 2022; 28: 188–93.","DOI":"10.1097\/SPV.0000000000001094"},{"key":"10.3238\/arztebl.m2022.0406_ref71","doi-asserted-by":"crossref","unstructured":"van IJsselmuiden MN, van Oudheusden A, Veen J, et al.: Hysteropexy in the treatment of uterine prolapse stage 2 or higher: laparoscopic sacrohysteropexy versus sacrospinous hysteropexy—a multicentre randomised controlled trial (LAVA trial). BJOG 2020; 127: 1284–93.","DOI":"10.1111\/1471-0528.16242"},{"key":"10.3238\/arztebl.m2022.0406_ref72","doi-asserted-by":"crossref","unstructured":"Lucot JP, Cosson M, Bader G, et al.: Safety of vaginal mesh surgery versus laparoscopic mesh sacropexy for cystocele repair: results of the prosthetic pelvic floor repair randomized controlled trial. Eur Urol 2018; 74: 167–76.","DOI":"10.1016\/j.eururo.2018.01.044"},{"key":"10.3238\/arztebl.m2022.0406_ref73","doi-asserted-by":"crossref","unstructured":"Lucot JP, Cosson M, Verdun S, et al.: Long-term outcomes of primary cystocele repair by transvaginal mesh surgery versus laparoscopic mesh sacropexy: extended follow up of the PROSPERE multicentre randomised trial. BJOG 2022; 129: 127–37.","DOI":"10.1111\/1471-0528.16847"},{"key":"10.3238\/arztebl.m2022.0406_ref74","doi-asserted-by":"crossref","unstructured":"Bataller E, Ros C, Angl\u00e8s S, Gallego M, Espu\u00f1a-Pons M, Carmona F: Anatomical outcomes 1 year after pelvic organ prolapse surgery in patients with and without a uterus at a high risk of recurrence: a randomised controlled trial comparing laparoscopic sacrocolpopexy\/cervicopexy and anterior vaginal mesh. Int Urogynecol J 2019; 30: 545–55.","DOI":"10.1007\/s00192-018-3702-7"},{"key":"10.3238\/arztebl.m2022.0406_ref75","doi-asserted-by":"crossref","unstructured":"Coolen AWM, van IJsselmuiden MN, van Oudheusden AMJ, et al.: Laparoscopic sacrocolpopexy versus vaginal sacrospinous fixation for vaginal vault prolapse, a randomized controlled trial: SALTO-2 trial, study protocol. BMC Womens Health 2017; 17: 52.","DOI":"10.1186\/s12905-017-0402-2"},{"key":"10.3238\/arztebl.m2022.0406_ref76","doi-asserted-by":"crossref","unstructured":"No\u00e9 KG, Schiermeier S, Alkatout I, Anapolski M: Laparoscopic pectopexy: a prospective, randomized, comparative clinical trial of standard laparoscopic sacral colpocervicopexy with the new laparoscopic pectopexy-postoperative results and intermediate-term follow-up in a pilot study. J Endourol 2015; 29: 210–5.","DOI":"10.1089\/end.2014.0413"},{"key":"10.3238\/arztebl.m2022.0406_ref77","doi-asserted-by":"crossref","unstructured":"Schulten SFM, Detollenaere RJ, Stekelenburg J, IntHout J, Kluivers KB, van Eijndhoven HWF: Sacrospinous hysteropexy versus vaginal hysterectomy with uterosacral ligament suspension in women with uterine prolapse stage 2 or higher: observational follow-up of a multicentre randomised trial. BMJ 2019; 366: l5149.","DOI":"10.1136\/bmj.l5149"},{"key":"10.3238\/arztebl.m2022.0406_ref78","doi-asserted-by":"crossref","unstructured":"Jelovsek JE, Barber MD, Brubaker L, et al.: Effect of uterosacral ligament suspension vs sacrospinous ligament fixation with or without perioperative behavioral therapy for pelvic organ vaginal prolapse on surgical outcomes and prolapse symptoms at 5 years in the OPTIMAL randomized clinical trial. JAMA 2018; 319: 1554–65.","DOI":"10.1001\/jama.2018.2827"},{"key":"10.3238\/arztebl.m2022.0406_ref79","doi-asserted-by":"crossref","unstructured":"Ahmed AA, Abdellatif AH, El-Helaly HA, et al.: Concomitant transobturator tape and anterior colporrhaphy versus transobturator subvesical mesh for cystocele-associated stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2019; 31: 1633–40.","DOI":"10.1007\/s00192-019-04068-8"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T10:33:24Z","timestamp":1701772404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":79,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2022.0406","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}